Pathstone Holdings’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.2M | Buy |
150,524
+11,627
| +8% | +$1.25M | 0.06% | 207 |
|
|
2025
Q1 | $14M | Buy |
138,897
+12,806
| +10% | +$1.29M | 0.06% | 242 |
|
|
2024
Q4 | $11.3M | Buy |
126,091
+1,659
| +1% | +$148K | 0.05% | 263 |
|
|
2024
Q3 | $10.4M | Buy |
124,432
+170
| +0.1% | +$14.2K | 0.05% | 306 |
|
|
2024
Q2 | $9.57M | Buy |
124,262
+7,398
| +6% | +$570K | 0.04% | 309 |
|
|
2024
Q1 | $8M | Sell |
116,864
-7,517
| -6% | -$515K | 0.04% | 372 |
|
|
2023
Q4 | $7.2M | Buy |
+124,381
| New | +$7.2M | 0.04% | 334 |
|